Tower Research Capital LLC (Trc) Immuneering Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Immuneering Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,400 shares of IMRX stock, worth $4,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,400
Previous 1,968
21.95%
Holding current value
$4,224
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IMRX
# of Institutions
44Shares Held
4.59MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$1.86 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD767KShares$1.35 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$938,7200.0% of portfolio
-
Morgan Stanley New York, NY454KShares$799,2160.0% of portfolio
-
Southport Management, L.L.C. Wilson, WY215KShares$378,4001.71% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $46.5M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...